11:37 ET Berger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary Duties
I'm PortAI, I can summarize articles.
Berger Montague is investigating Hims & Hers Health Inc. (NYSE: HIMS) for potential breaches of fiduciary duties by its Board of Directors. This investigation follows Novo Nordisk A/S's termination of its partnership with Hims & Hers, citing deceptive marketing practices related to unapproved compounded versions of semaglutide. Shareholders can contact Berger Montague for more information regarding the investigation.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: prnewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments